Focus: Metaphore Biotechnologies is a Boston-based biotech company pioneering therapeutics based on biomimicry principles, with a diversified pipeline spanning five therapeutic areas including neurology, oncology, and infectious diseases.
Profile data last refreshed 42m ago · AI intelligence enriched 2w ago
Hot — 71 jobs added in 30d
Net +26 (71 new, 45 removed). Aggressive expansion phase.
Metaphore is a high-risk, early-stage platform play best suited for scientists seeking discovery-focused roles and equity upside, not stability-oriented professionals or those needing near-term clinical validation.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Metaphore Biotechnologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Metaphore Biotechnologies's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles